Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Drug therapy to reduce early readmission risk in heart failure: ready for prime time?

Authors
  • Vaduganathan, Muthiah
  • Fonarow, Gregg C
  • Gheorghiade, Mihai
Type
Published Article
Journal
JACC. Heart failure
Publication Date
Aug 01, 2013
Volume
1
Issue
4
Pages
361–364
Identifiers
DOI: 10.1016/j.jchf.2013.04.010
PMID: 24621940
Source
Medline
Keywords
License
Unknown

Abstract

Readmission for heart failure remains a major focus of policymakers, clinicians, and patients. Despite meeting key national performance measures and frequent use of evidence-based therapies, rates of 30-day post-discharge rehospitalization may be as high as 25%. Digoxin and mineralocorticoid antagonists are known to reduce admissions for heart failure, but are significantly underused in current clinical practice despite their proven benefits.

Report this publication

Statistics

Seen <100 times